A groundbreaking 1.3 million patient study reveals that GLP-1 medications like Ozempic and Mounjaro reduce alcohol binging by 50% and show remarkable promise for opioid addiction treatment. This revolutionary discovery is transforming how we approach addiction recovery in 2025.
Gambling addiction, clinically known as gambling disorder, represents a complex behavioral addiction that affects millions of Canadians. This condition transcends simple recreational betting, evolving into a compulsive behavior that hijacks the brain's reward system.
Eye Movement Desensitization and Reprocessing (EMDR) therapy represents a revolutionary approach to addiction treatment that addresses the fundamental connection between trauma and substance use disorders. Developed by Dr. Francine Shapiro in the late 1980s, EMDR has evolved from treating post-traumatic stress disorder to becoming a cornerstone therapy in comprehensive addiction recovery programs.
Canada is grappling with a significant public health challenge as binge drinking and substance abuse wreak havoc on communities nationwide. This crisis not only affects individuals but also strains families and healthcare systems.